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Background/Aims: This study aimed to evaluate the diag-
nostic role of low serum amylase and lipase values in the 
detection of chronic pancreatitis. Methods: Patients under-
went endoscopic retrograde cholangiopancreatography and 
were diagnosed with non-calcific chronic pancreatitis (NCCP; 
n=99) and calcific chronic pancreatitis (CCP; n=112). Patient 
serum amylase and lipase values were compared with those 
of healthy controls (H; n=170). Results: The median serum 
amylase (normal range, 19 to 86 U/L) and lipase values (7 
to 59 U/L) (P25–P75) were 47.0 (39.8 to 55.3) and 25.0 (18.0 
to 35.0) for H, 34.0 (24.5 to 49.0) and 19.0 (9.0 to 30.0) 
for NCCP, and 30.0 (20.0 to 40.8) and 10.0 (3.0 to 19.0) for 
CCP, respectively. The cutoff values with the highest diagnos-
tic accuracy for discriminating NCCP from H were 40 U/L for 
amylase and 20 U/L for lipase, respectively, and for CCP from 
H were 38 U/L for amylase and 15 U/L for lipase, respec-
tively. For the diagnosis of NCCP with a criterion of serum 
amylase <40 and lipase <20 U/L, the sensitivity, specificity, 
positive predictive value, and negative predictive values were 
37.4%, 88.8%, 66.1%, and 70.9%, respectively. Conclusions: 
Serum amylase and/or lipase levels below the normal serum 
range are highly specific for chronic pancreatitis patients. 
Clinicians should not ignore low serum pancreatic enzyme 
values. (Gut Liver 2017;11:878-883)
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INTRODUCTION
Achieving a diagnosis of disease with a simple method is 
helpful in clinical practice. Chronic pancreatitis encompasses a 
wide range of progressive fibro-inflammatory diseases of the 
exocrine pancreas that eventually lead to damage of the gland. 
With progression, failure of exocrine and endocrine pancre-
atic function eventually may occur.1 Chronic pancreatitis may 
initially present with clinically apparent acute pancreatitis. 
Repeated episodes of acute pancreatitis progress to develop-
ment of established chronic pancreatitis, with intraductal stones, 
pancreatic ductal distortion, strictures and pancreatic atrophy.2,3 
Clinically, eventual extensive destruction of the pancreatic 
parenchyma may result in malabsorption and steatorrhea, and 
diabetes mellitus. 
The pancreas synthesizes and secretes more than 10 enzymes, 
including amylase and lipase, that hydrolyze macronutrients 
including carbohydrate, fat and protein within the lumen of the 
small bowel. Serum amylase and lipase values have been widely 
used for the diagnosis of acute inflammatory states of the pan-
creas. As the secretory capacity of the pancreas decreases dur-
ing the course of chronic pancreatitis, serum amylase and lipase 
values may decrease according to the residual functional capac-
ity.3 
In clinical practice, when serum pancreatic enzyme values 
are elevated, further pancreatic evaluation is often warranted. 
In contrast, when the value is normal or low, no specific next 
step is suggested. Previous studies published a few decades ago 
suggested the diagnostic role of low pancreatic serum enzyme 
values in chronic pancreatitis.4-7 In a recent study, low serum 
pancreatic lipase value was a useful indicator for the discrimi-
nation of established calcific chronic pancreatitis (CCP) versus 
healthy controls (H).8 The low lipase finding is of less diagnostic 
value since the diagnosis is obvious via calcification. To date, 
few studies addressed the diagnostic role of serum amylase and 
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lipase in the discrimination of chronic pancreatitis at the non-
calcific stage of disease from H. This study aimed to evaluate 
the diagnostic role of low serum pancreatic amylase and lipase 
values in the detection of non-calcific chronic pancreatitis 
(NCCP).
MATERIALS AND METHODS
Healthy paid volunteers were screened and prospectively 
enrolled in the control group.8 Consecutive patients who were 
diagnosed with chronic pancreatitis at Indiana University Hos-
pital were selected from the Indiana University endoscopic 
retrograde cholangiopancreatography (ERCP) database during 
the period between December 2012 and November 2015 and 
enrolled in the patient groups. Patients with chronic pancreatitis 
were divided into NCCP and CCP group based on the presence 
or absence of calcification seen on computed tomography (CT) 
scan, plain abdominal X-ray or ERCP. Serum amylase and li-
pase values were compared among the three groups. This study 
was approved by Indiana University Institutional Review Board 
(No. 1310570729A006). 
1. Control group
Healthy volunteers were screened and prospectively enrolled 
in the control group from April 1, 2014 to March 15, 2015. 
Informed consent was obtained from all volunteers before en-
rollment. Inclusion criteria and exclusion criteria were described 
in our previous study. Aliquots of blood samples from a single 
draw were analyzed for serum pancreatic enzyme levels. 
2. Patient group
Patients who were diagnosed with chronic pancreatitis based 
on ERCP (endoscopic ultrasound [EUS] in selected cases) at In-
diana University between December 2012 and November 2015 
were enrolled in the patient group. All information was ob-
tained by retrospective medical record review from patients who 
were identified through the Indiana University ERCP database. 
NCCP was diagnosed based on at least one of three imaging 
studies (CT, n=40; magnetic resonance imaging [MRI], n=56; 
EUS, n=47) with parenchymal and ductal changes except cal-
cification, and confirmed with endoscopic retrograde pancrea-
tography abnormalities. NCCP was classified into two categories 
(mild/moderate and severe) based on the severity of pancrea-
tography findings according to the published criteria.4 CCP was 
diagnosed based on clinical symptoms and pancreatic calcifica-
tions as well as parenchymal and ductal changes detected by 
imaging studies (CT, n=69; MRI, n=17; EUS, n=18; fluoroscopy, 
n=8) and confirmed with ERP abnormalities. Blood samples for 
serum amylase and lipase values were obtained and analyzed a 
few hours before the ERCP by the routine clinical laboratory of 
the Indiana University Health. Patients were excluded from the 
study if they were younger than 18 years or older than 79 years 
or pregnant or had a condition such as chronic kidney disease, 
previous gastrointestinal or pancreatic surgery that may affect 
serum amylase and lipase levels. 
3. Analysis of serum pancreatic enzymes 
All serum amylase and lipase values in the three groups were 
measured using same automated chemistry analyzer (AU 5822 
analyzer; Beckman Coulter, Brea, CA, USA). Our validated refer-
ence range for amylase and lipase are between 19 U/L and 86 
U/L, and between 7 U/L and 59 U/L, respectively. 
Serum amylase and lipase values were compared among the 
three groups. Patients with above the upper normal range of se-
rum enzyme value (amylase >86 U/L and lipase >59 U/L) before 
ERCP were excluded in the study.
Table 1. Baseline Characteristics of Enrolled Subjects
Characteristic Healthy (n=170) NCCP (n=99) CCP (n=112) p-value
Age, yr 49.0 (32.8–62.0) 50.6 (39.2–62.2) 53.7 (46.0–63.8)* 0.020
Male sex 44 (25.9) 38 (38.4) 51 (45.6)* 0.002
Amylase, U/L† 47.0 (39.8–55.3) 34.0 (24.5–49.0)‡ 31.7 (20.0–40.8)‡,§ <0.001
Lipase, U/LΙΙ 25.0 (18.0–35.0) 22.3 (9.0–30.0)† 10.0 (3.0–19.0)‡,¶ <0.001
Cause of pancreatitis
    Alcohol - 19 63
    Idiopathic - 57 24
    Smoking - 6 2
    Autoimmune - 5 0
    Pancreas divisum - 5 8
    Others - 3 9
Data are presented as median (P25–P75) or number (%).
NCCP, non-calcific chronic pancreatitis; CCP, calcific chronic pancreatitis; P25–P75, 25th and 75th percentiles.
*p<0.05; †Normal value, 19–86 U/L; ‡p<0.001 compared to healthy individuals; §p<0.05; ΙΙNormal value, 7–59 U/L; ¶p<0.001 between NCCP and 
CCP.
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4. Statistical analysis
Values are expressed as median with 25th and 75th percen-
tiles (P25–P75) or absolute number. For comparison of continuous 
values, the values were first evaluated for normality of distribu-
tion using the Shapiro-Wilk test. As age, serum amylase and 
lipase values did not pass the normality test, they were analyzed 
using Kruskal-Wallis test followed by Mann-Whiney U test with 
Bonferroni correction.
Separate receiver operator characteristic (ROC) curves were 
plotted using serum amylase and lipase values to predict chron-
ic pancreatitis. The area under each ROC curve, a measure of 
predictive power, was calculated. For both serum amylase and 
lipase, a cutoff value was selected to maximize the proportion 
of correct discrimination of chronic pancreatitis. Sensitivity and 
specificity were determined using these values. Sensitivity, spec-
ificity, positive predictive value (PPV), and negative predictive 
value (NPV) were compared using two-sample tests of propor-
tions. Using same method, cutoff at 0, 10, 20, and 30 percentile 
of normal range of serum amylase and cutoff at 0, 5, 10, and 
15 percentile of normal range of serum lipase were selected to 
compare sensitivity, specificity, PPV, and NPV. A p-value <0.05 
was considered significant. All analyses were performed using 
SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). 
RESULTS
1. Serum amylase and lipase values
Baseline characteristics and mean serum amylase and lipase 
values are summarized in Table 1. Median age (P25–P75) was 49.0 
years (32.8 to 62.0 years) for H, 50.6 years (39.2 to 62.2 years) 
for NCCP, and 53.7 years (46.0 to 63.8 years) for CCP, respec-
tively. The proportion of male subjects was 25.9% for H, 38.4% 
for NCCP, and 45.6% for CCP, respectively. Median serum amy-
lase value (normal range, 19 to 86 U/L; P25–P75) was 47.0 U/L 
(39.8 to 55.3 U/L) for H, 34.0 U/L (24.5 to 49.0 U/L) for NCCP, 
31.7 U/L (20.0 to 40.8 U/L) for CCP (p<0.001). Median serum li-
pase value (normal range, 7 to 59 U/L; P25–P75) was 25.0 U/L (18.0 
to 35.0 U/L) for H, 22.3 U/L (9.0 to 30.0 U/L) for NCCP, 10.0 U/
L (3.0 to 19.0 U/L) for CCP (p<0.001). Fig. 1 shows the distribu-
tion of serum amylase (A) and lipase (B) values among the five 
groups. 
Median serum amylase values (P25–P75) were compared ac-
cording to the severity of chronic pancreatitis; 34.0 U/L (27.0 to 
48.0 U/L) for moderate NCCP (n=66), 34.5 U/L (22.3 to 56.5 U/
L) for severe NCCP (n=33), and 30.0 U/L (20.0 to 40.8 U/L) for 
CCP. There was significant difference between moderate NCCP 
and CCP (p<0.05), but no difference between severe NCCP and 
CCP (p=0.119). For serum lipase values, median values (P25–
P75) were 20.0 U/L (12.8 to 30.5 U/L) for moderate NCCP (n=66), 
15.0 U/L (4.0 to 32.0 U/L) for severe NCCP (n=33), and 10.0 U/
L (3.0 to 19.0 U/L) for CCP. There was also significant difference 
between moderate NCCP and CCP (p<0.001), but no significant 
difference between severe NCCP and CCP (p=0.056).
2. Cutoff values of serum amylase and lipase between H 
and NCCP
Sensitivity and specificity curves demonstrated that the op-
timal cutoff value for serum amylase and lipase corresponded 
to the intersection of the sensitivity and specificity curves (Fig. 
2). Serum amylase with a cutoff value of 40 U/L provided the 
greatest diagnostic accuracy with sensitivity of 56.6% and 
specificity of 75.3% for differentiating between H and NCCP. 









































Fig. 1. Serum amylase (A) and lipase (B) values among the five groups.
H, healthy control group; NCCP, non-calcific chronic pancreatitis; mNCCP, moderate NCCP; sNCCP, severe NCCP; CCP, calcific chronic pancreati-
tis. *p<0.05; †p<0.001.
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greatest accuracy with sensitivity of 54.5% and specificity of 
68.8%. With combined use of optimal cutoff values of <40 U/
L for serum amylase and <20 U/L for serum lipase, diagnostic 
accuracy with sensitivity of 37.4% and specificity of 88.8% was 
observed (Table 2). Diagnostic parameters at four different cut-
off values that correspond to four different percentiles are also 
summarized at Table 2.
3. Cutoff values of serum amylase and lipase between H 
and CCP
Sensitivity and specificity curves demonstrated that the op-
timal cutoff value for serum amylase and lipase corresponded 
to the intersection of the sensitivity and specificity curves (Fig. 
3). Serum amylase with a cutoff value of 38 U/L provided the 
greatest diagnostic accuracy with sensitivity of 70.5% and spec-
ificity of 81.2% for differentiating between H and CCP. Serum 
lipase value with a cutoff value of 15 U/L provided the greatest 
accuracy with sensitivity of 67.0% and specificity of 86.5%. 
With combined use of optimal cutoff values of <38 U/L for se-
rum amylase and <15 U/L for serum lipase, diagnostic accuracy 
with sensitivity of 55.4% and specificity of 93.5% was observed 







































Fig. 2.  (A) Sensitivity and specificity curves of serum amylase values to differentiate between healthy subjects and non-calcific chronic pancreati-
tis. Optimal cutoff values of 40 U/mL for amylase correlated with the crossover of the sensitivity and specificity curves. (B) Sensitivity and speci-
ficity curves of serum lipase values to differentiate between healthy subjects and non-calcific chronic pancreatitis. Optimal cutoff values of 20 U/L 
for lipase correlated with the crossover of the sensitivity and specificity curves.
Table 2. Diagnostic Accuracy of Serum Amylase and Lipase to Differentiate Non-Calcific Chronic Pancreatitis from Healthy Subjects
Percentile Sensitivity, % Specificity, % PPV, % NPV, % 
Amylase, U/L* 
    19.0  0 10.6 100.0 100.0 65.6
    25.7 10 25.3 94.7 73.5 68.5
    32.4 20 44.4 90.6 73.3 73.3
    39.1 30 56.6 75.3 57.1 74.9
    40.0 Optimal cutoff 56.6 75.3 57.1 74.9
Lipase, U/L† 
    7.0 0 15.2 100.0 100.0 66.9
    9.6 5 25.3 95.9 78.1 68.8
    12.2 10 31.3 92.4 70.5 68.8
    14.8 15 33.3 86.5 58.9 69.0
    17.4 20 41.4 75.9 50.5 69.0
    20.0 Optimal cutoff 54.5 68.8 50.0 72.2
Amylase <40 and lipase <20 U/L 37.4 88.8 66.1 70.9
Amylase <40 or lipase <20 U/L 73.7 55.3 49.0 78.3
PPV, positive predictive value; NPV, negative predictive value.
*Normal, 19–86 U/L; †Normal, 7–59 U/L.
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that correspond to four different percentiles are also summa-
rized at Table 3.
DISCUSSION
This study demonstrates that the low serum amylase and li-
pase values have been rediscovered as an important and useful 
predictor for the detection of NCCP as well as CCP.
For the viewpoint of statistical analysis, optimal cutoff values 
for serum amylase and lipase were set at 40 U/L and 20 U/L 
for the comparison between H and NCCP with modest sensitiv-
ity and specificity, and 38 U/L and 15 U/L for the comparison 
between H and CCP with an increased diagnostic accuracy. 
However, in clinical practice, it is better to predict whether the 
patient has a lower possibility of chronic pancreatitis with these 
serum amylase and lipase test as the incidence rate of chronic 
pancreatitis, about 4 per 100,000 people (or person-years), is 
relatively low.9,10 Therefore, the cutoff values at a higher speci-
ficity (≥90%), 32 U/L for amylase and 12 U/L for lipase, have 
greater predictive value for the absence of chronic pancreatitis.
The current study confirmed that serum pancreatic enzymes 
decline with worsening chronic pancreatitis. The median serum 
amylase and lipase values showed a tendency to decrease when 
the values from moderate and severe NCCP were compared with 
those of CCP. Serum lipase value tended to decrease more obvi-








































Fig. 3. (A) Sensitivity and specificity curves of serum amylase values to differentiate between healthy subjects and calcific chronic pancreatitis. 
Optimal cutoff values of 38 U/mL for amylase correlated with the crossover of the sensitivity and specificity curves. (B) Sensitivity and specificity 
curves of serum lipase values to differentiate between healthy subjects and calcific chronic pancreatitis. Optimal cutoff values of 15 U/L for lipase 
correlated with the crossover of the sensitivity and specificity curves.
Table 3. Diagnostic Accuracy of Serum Amylase and Lipase for Differentiating Calcific Chronic Pancreatitis from Healthy Subjects
Percentile Sensitivity, % Specificity, % PPV, % NPV, % 
Amylase, U/L* 
    19.0 0 21.4 100.0 100.0 65.9
    25.7 10 41.1 94.7 83.6 70.9
    32.4 20 53.6 90.6 78.9 74.8
    38.0 Optimal cutoff 70.5 81.2 71.2 80.5
    39.1 30 72.3 75.3 65.9 80.7
Lipase, U/L† 
    7.0 0 39.3 100.0 100.0 71.4
    9.6 5 47.3 95.9 88.3 73.4
    12.2 10 58.9 92.4 83.5 77.3
    14.8 15 67.0 86.5 76.5 79.9
    15.0 Optimal cutoff 67.0 86.5 76.5 79.9
Amylase <38 and lipase <15 U/L 55.4 93.5 84.9 76.1
Amylase <38 or lipase <15 U/L 82.1 74.1 67.6 86.3
PPV, positive predictive value; NPV, negative predictive value.
*Normal, 19–86 U/L; †Normal, 7–59 U/L.
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addition, serum lipase value showed a higher diagnostic accu-
racy in detection of CCP from H compared with serum amylase 
value.
Very low values of serum trypsin were observed in patients 
with advanced chronic pancreatitis, with low sensitivities of 
33% to 65%.11-13 A very low level of serum trypsin (<20 ng/
mL; mean serum values [±2 standard deviation] for H were 45.9 
[±26.9]) is reasonably specific for advanced chronic pancreatitis 
with steatorrhea.12 The serum trypsin assay has not replaced 
amylase and lipase test in clinical practice due to requiring 
several days to obtain a result, and 2- to 4-fold more expensive 
than serum amylase and lipase tests. 
There are some limitations in this study. This study was 
conducted as retrospective review of patients with chronic pan-
creatitis. Prospective evaluation of NCCP with EUS may better 
allow defining the relationship between serum amylase and 
lipase level and natural course of NCCP. Although consecutive 
patients with chronic pancreatitis were analyzed to minimize 
the selection bias, only one-fifth of NCCP patients presumably 
had early stage of chronic pancreatitis; 21 of 99 NCCP patients 
showed normal CT and/or MR finding and 20 of 99 patients 
were diagnosed based on EUS. Even if these patients are NCCP, 
patients with advanced form of NCCP were probably selected in 
this study and it may increase the possibility of selection bias. 
A prospective study that involves patients who show normal 
CT and/or MR finding, and are diagnosed as NCCP only with 
EUS will discover further. Lastly, the optimal cutoff values for 
serum amylase (40 U/L) and lipase (20 U/L) for the comparison 
between H and NCCP have a relatively low sensitivity. There-
fore, it is better to use strict cutoff values at a higher specificity 
(>90%) to exclude the possibility of chronic pancreatitis and to 
consider further study in the highly selected patients to evaluate 
the presence of chronic pancreatitis. The real clinical value of 
these amylase and lipase values is aforementioned (in the sec-
ond paragraph of Discussion) noting that very low values have 
low sensitivity but very high specificity for chronic pancreatitis. 
Therefore, the occasional patient with very low lipase (in the 
absence of surgical resection) has high probability of chronic 
pancreatitis.
In conclusion, serum amylase and/or lipase below the serum 
normal range have high specificity for chronic pancreatitis. Low 
normal range serum amylase and/or lipase suggests chronic 
pancreatitis but with lower specificity. When combined amylase 
and lipase values are low, these should not be discarded, and 
further testing may well be warranted if there is the possibility 
of underlying pancreatic disease.
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